CIK 0001563665
- Non-accelerated filer
- Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455210462
- Phone
- +1 774-233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- 4 Open-market buy 10% owner bought 8,700 shares at an average $2.37 ($20,620)
- 4 Open-market buy 10% owner bought 5,200 shares at an average $2.15 ($11,180)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CMO bought 100,000 shares at $0.37 ($37,000)
- 4 Open-market buy President and CMO bought 150,000 shares at $0.32 ($48,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.91 ($9,100)
- 4 Open-market buy Director bought 16,182 shares at $0.93 ($15,033)
- 4 Open-market buy President and CEO bought 25,000 shares at $0.96 ($24,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 20,000 shares at $1.07 ($21,400)
- 4 Open-market buy Director bought 32,000 shares at $1.17 ($37,475)
- 4 Open-market buy Director bought 17,241 shares at $1.46 ($25,172)
- 4 Open-market buy Director bought 6,500 shares at $1.56 ($10,139)
Page 8 of 12 · 235 filings